Parents' Enhanced Reminder Intervention to Improve Children's Timely Completion of Immunization Series of Pneumococcal Vaccine at the 12-month's Visit
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pneumococcal Vaccines
- Sponsor
- Ottawa Hospital Research Institute
- Enrollment
- 700
- Locations
- 1
- Primary Endpoint
- Receipt of 12-month pneumococcal vaccine
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this clinical trial is to assess the effectiveness of enhanced email reminders in improving vaccine coverage at the 12-month visit in CANImmunize app users. The main questions it aims to answer are:
- Do enhanced email reminders improve coverage of the 12- month dose of the pneumococcal vaccine and the timely completion of its immunization series at the 12-month's visit in CANImmunize app users?
- What are the predictors of predictors of timely completion of the 12-month's series of pneumococcal vaccines in the CANImmunize app users?
Participants will be randomized to either receive enhanced reminder/recall materials via email or the standard CANImmunize notifications. Researchers will compare the enhanced reminder group to the standard notification group to see if there is a difference in vaccine coverage at the 12-month visit.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Receipt of 12-month pneumococcal vaccine
Time Frame: 12 months of age
Receipt of the 12-month dose of the pneumococcal vaccine as recorded in the CANImmunize immunization record
Secondary Outcomes
- Timeliness of 12-month pneumococcal vaccine(12-13 months of age will be considered as timely, after 13 months considered late)